By Helgi Library - December 4, 2020
Lenzing Biocel Paskov employed 407 employees in 2019, up 3.56% compared to the previous year. Historically, between 200...
By Helgi Library - December 4, 2020
Lenzing Biocel Paskov employed 407 employees in 2019, up 3.56% compared to the previous year. Historically, between 200...
By Helgi Library - December 4, 2020
Lenzing Biocel Paskov made a net profit of CZK 1,111 mil in 2019, down 21.6% compared to the previous year. Total sales reached CZK ...
| Profit Statement | 2017 | 2018 | 2019 | |
| Sales | CZK mil | 5,568 | 5,249 | 5,285 |
| Gross Profit | CZK mil | 2,105 | 1,710 | 2,015 |
| EBITDA | CZK mil | 2,327 | 2,083 | 1,938 |
| EBIT | CZK mil | 1,909 | 1,662 | 1,530 |
| Financing Cost | CZK mil | 14.4 | 0 | 0 |
| Pre-Tax Profit | CZK mil | 1,957 | 1,672 | 1,405 |
| Net Profit | CZK mil | 1,621 | 1,417 | 1,111 |
| Dividends | CZK mil | 1,770 | 1,100 | ... |
| Balance Sheet | 2017 | 2018 | 2019 | |
| Total Assets | CZK mil | 8,216 | 7,362 | 7,358 |
| Non-Current Assets | CZK mil | 4,246 | 4,070 | 3,994 |
| Current Assets | CZK mil | 3,969 | 3,291 | 33,612 |
| Working Capital | CZK mil | 1,513 | 1,760 | 1,347 |
| Shareholders' Equity | CZK mil | 6,711 | 6,249 | 6,303 |
| Liabilities | CZK mil | 1,505 | 1,113 | 1,056 |
| Total Debt | CZK mil | 409 | 0 | 0 |
| Net Debt | CZK mil | -1,706 | -1,143 | -1,587 |
| Ratios | 2017 | 2018 | 2019 | |
| ROE | % | 26.8 | 21.9 | 17.7 |
| ROCE | % | 28.2 | 24.5 | 19.9 |
| Gross Margin | % | 37.8 | 32.6 | 38.1 |
| EBITDA Margin | % | 41.8 | 39.7 | 36.7 |
| EBIT Margin | % | 34.3 | 31.7 | 29.0 |
| Net Margin | % | 29.1 | 27.0 | 21.0 |
| Net Debt/EBITDA | -0.733 | -0.549 | -0.819 | |
| Net Debt/Equity | % | -25.4 | -18.3 | -25.2 |
| Cost of Financing | % | 2.31 | 0 | ... |
| Cash Flow | 2017 | 2018 | 2019 | |
| Total Cash From Operations | CZK mil | 2,394 | 1,452 | 1,802 |
| Total Cash From Investing | CZK mil | -341 | -245 | -259 |
| Total Cash From Financing | CZK mil | -894 | -2,179 | 1,100 |
| Net Change In Cash | CZK mil | 1,159 | -971 | 2,643 |
| Cash Conversion Cycle | days | 129 | 150 | 122 |
| Cash Earnings | CZK mil | 2,039 | 1,839 | 1,519 |
| Free Cash Flow | CZK mil | 2,052 | 1,207 | 1,543 |
Get all company financials in excel:
| overview | Unit | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 |
| income statement | |||||||||||||||
| Sales | CZK mil | ... | 4,330 | 5,259 | 5,618 | 5,126 | 5,568 | ||||||||
| Gross Profit | CZK mil | ... | 583 | 1,167 | 1,778 | 1,591 | 2,105 | ||||||||
| EBIT | CZK mil | ... | 163 | 940 | 1,511 | 1,375 | 1,909 | ||||||||
| Net Profit | CZK mil | ... | -39.1 | 575 | 996 | 1,297 | 1,621 | ||||||||
| ROE | % | ... | -1.51 | 20.7 | 28.1 | 27.3 | 26.8 | ||||||||
| EBIT Margin | % | ... | 3.76 | 17.9 | 26.9 | 26.8 | 34.3 | ||||||||
| Net Margin | % | ... | -0.904 | 10.9 | 17.7 | 25.3 | 29.1 | ||||||||
| Employees | 398 | 384 | 369 | 368 | 380 | ||||||||||
| balance sheet | |||||||||||||||
| Total Assets | CZK mil | ... | 6,500 | 6,846 | 7,082 | 7,067 | 8,216 | ||||||||
| Non-Current Assets | CZK mil | ... | 5,113 | 4,876 | 4,541 | 4,343 | 4,246 | ||||||||
| Current Assets | CZK mil | ... | 1,386 | 1,969 | 2,539 | 2,722 | 3,969 | ||||||||
| Shareholders' Equity | CZK mil | ... | 2,597 | 2,962 | 4,130 | 5,364 | 6,711 | ||||||||
| Liabilities | CZK mil | ... | 3,903 | 3,884 | 2,952 | 1,703 | 1,505 | ||||||||
| Non-Current Liabilities | CZK mil | ... | 200 | 560 | 144 | 618 | 330 | ||||||||
| Current Liabilities | CZK mil | ... | 2,010 | 1,972 | 1,868 | 983 | 834 | ||||||||
| Net Debt/EBITDA | ... | 5.40 | 1.65 | 0.268 | -0.065 | -0.733 | |||||||||
| Net Debt/Equity | % | ... | 105 | 78.8 | 12.8 | -2.21 | -25.4 | ||||||||
| Cost of Financing | % | ... | ... | ... | ... | ... | ... | ... | ... | 2.83 | 9.61 | 2.57 | 2.31 | ... | |
| cash flow | |||||||||||||||
| Total Cash From Operations | CZK mil | ... | ... | -449 | -99.8 | 834 | 1,730 | 2,394 | |||||||
| Total Cash From Investing | CZK mil | ... | ... | -634 | 714 | 798 | -245 | -341 | |||||||
| Total Cash From Financing | CZK mil | ... | ... | 969 | -254 | -1,297 | -1,296 | -894 | |||||||
| Net Change In Cash | CZK mil | ... | ... | -113 | 360 | 336 | 188 | 1,159 |
| income statement | Unit | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 |
| income statement | |||||||||||||||
| Sales | CZK mil | ... | 4,330 | 5,259 | 5,618 | 5,126 | 5,568 | ||||||||
| Cost of Goods & Services | CZK mil | ... | 3,747 | 4,092 | 3,839 | 3,535 | 3,463 | ||||||||
| Gross Profit | CZK mil | ... | 583 | 1,167 | 1,778 | 1,591 | 2,105 | ||||||||
| Staff Cost | CZK mil | ... | 231 | 238 | 258 | 259 | 287 | ||||||||
| Other Operating Cost (Income) | CZK mil | ... | -155 | -488 | -455 | -499 | -509 | ||||||||
| EBITDA | CZK mil | ... | 507 | 1,417 | 1,975 | 1,831 | 2,327 | ||||||||
| Depreciation | CZK mil | ... | 344 | 477 | 464 | 456 | 418 | ||||||||
| EBIT | CZK mil | ... | 163 | 940 | 1,511 | 1,375 | 1,909 | ||||||||
| Net Financing Cost | CZK mil | ... | 209 | 228 | 596 | 23.1 | 47.9 | ||||||||
| Financing Cost | CZK mil | ... | ... | ... | ... | ... | ... | ... | ... | 78.9 | 195 | 27.4 | 14.4 | ||
| Extraordinary Cost | CZK mil | ... | 0 | 0 | 0 | 0 | -95.9 | ||||||||
| Pre-Tax Profit | CZK mil | ... | -46.0 | 712 | 915 | 1,352 | 1,957 | ||||||||
| Tax | CZK mil | ... | -6.89 | 137 | -81.0 | 55.1 | 106 | ||||||||
| Minorities | CZK mil | ... | 0 | 0 | ... | ... | ... | ... | ... | ||||||
| Net Profit | CZK mil | ... | -39.1 | 575 | 996 | 1,297 | 1,621 | ||||||||
| Net Profit Avail. to Common | CZK mil | ... | -39.1 | 575 | 996 | 1,297 | 1,621 | ||||||||
| Dividends | CZK mil | ... | ... | ... | ... | ... | ... | ... | ... | ... | 0 | 460 | 1,770 | ... | |
| growth rates | |||||||||||||||
| Total Revenue Growth | % | ... | ... | 14.6 | 21.5 | 6.82 | -8.76 | 8.63 | |||||||
| Staff Cost Growth | % | ... | ... | -29.8 | 2.91 | 8.37 | 0.517 | 10.6 | |||||||
| EBITDA Growth | % | ... | ... | 117 | 180 | 39.4 | -7.31 | 27.1 | |||||||
| EBIT Growth | % | ... | ... | -637 | 477 | 60.7 | -9.00 | 38.8 | |||||||
| Pre-Tax Profit Growth | % | ... | ... | -63.3 | -1,648 | 28.5 | 47.8 | 44.8 | |||||||
| Net Profit Growth | % | ... | ... | -60.5 | -1,570 | 73.1 | 30.2 | 25.0 | |||||||
| ratios | |||||||||||||||
| ROE | % | ... | -1.51 | 20.7 | 28.1 | 27.3 | 26.8 | ||||||||
| ROA | % | ... | -0.649 | 8.62 | 14.3 | 18.3 | 21.2 | ||||||||
| ROCE | % | ... | ... | -0.777 | 10.2 | 17.0 | 22.2 | 28.2 | |||||||
| Gross Margin | % | ... | 13.5 | 22.2 | 31.7 | 31.0 | 37.8 | ||||||||
| EBITDA Margin | % | ... | 11.7 | 27.0 | 35.2 | 35.7 | 41.8 | ||||||||
| EBIT Margin | % | ... | 3.76 | 17.9 | 26.9 | 26.8 | 34.3 | ||||||||
| Net Margin | % | ... | -0.904 | 10.9 | 17.7 | 25.3 | 29.1 | ||||||||
| Payout Ratio | % | ... | ... | ... | ... | ... | ... | ... | ... | ... | 0 | 35.5 | 109 | ... | |
| Cost of Financing | % | ... | ... | ... | ... | ... | ... | ... | ... | 2.83 | 9.61 | 2.57 | 2.31 | ... | |
| Net Debt/EBITDA | ... | 5.40 | 1.65 | 0.268 | -0.065 | -0.733 |
| balance sheet | Unit | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 |
| balance sheet | |||||||||||||||
| Cash & Cash Equivalents | CZK mil | ... | 70.5 | 431 | 766 | 955 | 2,113 | ||||||||
| Receivables | CZK mil | ... | 428 | 457 | 777 | 762 | 777 | ||||||||
| Inventories | CZK mil | ... | 649 | 928 | 996 | 1,005 | 1,078 | ||||||||
| Other ST Assets | CZK mil | ... | 240 | 154 | 0.384 | 0 | 0 | ||||||||
| Current Assets | CZK mil | ... | 1,386 | 1,969 | 2,539 | 2,722 | 3,969 | ||||||||
| Property, Plant & Equipment | CZK mil | ... | 5,099 | 4,866 | 4,535 | 4,338 | 4,242 | ||||||||
| LT Investments & Receivables | CZK mil | ... | 1.40 | 1.40 | 1.40 | 1.40 | 1.40 | ||||||||
| Intangible Assets | CZK mil | ... | 12.4 | 8.16 | 5.15 | 3.43 | 3.33 | ||||||||
| Goodwill | CZK mil | ... | 0 | 0 | 0 | 0 | 0 | ||||||||
| Non-Current Assets | CZK mil | ... | 5,113 | 4,876 | 4,541 | 4,343 | 4,246 | ||||||||
| Total Assets | CZK mil | ... | 6,500 | 6,846 | 7,082 | 7,067 | 8,216 | ||||||||
| Trade Payables | CZK mil | ... | 677 | 476 | 394 | 367 | 342 | ||||||||
| Short-Term Debt | CZK mil | ... | 1,445 | 1,270 | 1,297 | 405 | 409 | ||||||||
| Other ST Liabilities | CZK mil | ... | -112 | 226 | 177 | 211 | 83.2 | ||||||||
| Current Liabilities | CZK mil | ... | 2,010 | 1,972 | 1,868 | 983 | 834 | ||||||||
| Long-Term Debt | CZK mil | ... | 1,366 | 1,497 | 0 | 432 | 0 | ||||||||
| Other LT Liabilities | CZK mil | ... | -1,165 | -937 | 144 | 185 | 330 | ||||||||
| Non-Current Liabilities | CZK mil | ... | 200 | 560 | 144 | 618 | 330 | ||||||||
| Liabilities | CZK mil | ... | 3,903 | 3,884 | 2,952 | 1,703 | 1,505 | ||||||||
| Equity Before Minority Interest | CZK mil | ... | 2,597 | 2,962 | 4,130 | 5,364 | 6,711 | ||||||||
| Minority Interest | CZK mil | ... | 0 | 0 | 0 | 0 | 0 | ||||||||
| Equity | CZK mil | ... | 2,597 | 2,962 | 4,130 | 5,364 | 6,711 | ||||||||
| growth rates | |||||||||||||||
| Total Asset Growth | % | ... | ... | 16.8 | 5.32 | 3.45 | -0.210 | 16.3 | |||||||
| Shareholders' Equity Growth | % | ... | ... | 0.775 | 14.1 | 39.4 | 29.9 | 25.1 | |||||||
| Net Debt Growth | % | ... | ... | 59.6 | -14.8 | -77.3 | -122 | 1,338 | |||||||
| Total Debt Growth | % | ... | ... | 47.9 | -1.57 | -53.1 | -35.4 | -51.2 | ... | ||||||
| ratios | |||||||||||||||
| Total Debt | CZK mil | ... | 2,811 | 2,767 | 1,297 | 838 | 409 | ||||||||
| Net Debt | CZK mil | ... | 2,739 | 2,335 | 529 | -119 | -1,706 | ||||||||
| Working Capital | CZK mil | ... | 399 | 909 | 1,379 | 1,400 | 1,513 | ||||||||
| Capital Employed | CZK mil | ... | 5,512 | 5,785 | 5,920 | 5,743 | 5,759 | ||||||||
| Net Debt/Equity | % | ... | 105 | 78.8 | 12.8 | -2.21 | -25.4 | ||||||||
| Current Ratio | ... | 0.690 | 0.999 | 1.36 | 2.77 | 4.76 | |||||||||
| Quick Ratio | ... | 0.248 | 0.450 | 0.826 | 1.75 | 3.47 |
| cash flow | Unit | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 |
| cash flow | |||||||||||||||
| Net Profit | CZK mil | ... | -39.1 | 575 | 996 | 1,297 | 1,621 | ||||||||
| Depreciation | CZK mil | ... | 344 | 477 | 464 | 456 | 418 | ||||||||
| Non-Cash Items | CZK mil | ... | ... | -786 | -642 | -156 | -1.63 | 467 | |||||||
| Change in Working Capital | CZK mil | ... | ... | 32.6 | -510 | -470 | -21.3 | -113 | |||||||
| Total Cash From Operations | CZK mil | ... | ... | -449 | -99.8 | 834 | 1,730 | 2,394 | |||||||
| Capital Expenditures | CZK mil | ... | ... | -634 | 714 | 798 | -245 | -344 | |||||||
| Other Investing Activities | CZK mil | ... | ... | 0 | 0 | 0 | 0.132 | 2.22 | |||||||
| Total Cash From Investing | CZK mil | ... | ... | -634 | 714 | 798 | -245 | -341 | |||||||
| Dividends Paid | CZK mil | ... | ... | 59.1 | -210 | 172 | 0 | -460 | |||||||
| Issuance Of Shares | CZK mil | ... | ... | 0 | 0 | 1.00 | 0 | 0 | |||||||
| Issuance Of Debt | CZK mil | ... | ... | 910 | -44.1 | -1,470 | -460 | -429 | |||||||
| Other Financing Activities | CZK mil | ... | ... | 634 | -714 | -797 | -591 | 337 | |||||||
| Total Cash From Financing | CZK mil | ... | ... | 969 | -254 | -1,297 | -1,296 | -894 | |||||||
| Net Change In Cash | CZK mil | ... | ... | -113 | 360 | 336 | 188 | 1,159 | |||||||
| ratios | |||||||||||||||
| Days Sales Outstanding | days | ... | 36.1 | 31.7 | 50.5 | 54.3 | 50.9 | ||||||||
| Days Sales Of Inventory | days | ... | 63.2 | 82.7 | 94.7 | 104 | 114 | ||||||||
| Days Payable Outstanding | days | ... | 66.0 | 42.4 | 37.4 | 37.9 | 36.1 | ||||||||
| Cash Conversion Cycle | days | ... | 33.3 | 72.0 | 108 | 120 | 129 | ||||||||
| Cash Earnings | CZK mil | ... | 305 | 1,052 | 1,460 | 1,753 | 2,039 | ||||||||
| Free Cash Flow | CZK mil | ... | ... | -1,082 | 614 | 1,632 | 1,484 | 2,052 | |||||||
| Capital Expenditures (As % of Sales) | % | ... | ... | 14.6 | -13.6 | -14.2 | 4.79 | 6.17 |
| other ratios | Unit | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 |
| Employees | 398 | 384 | 369 | 368 | 380 | ||||||||||
| Cost Per Employee | USD per month | ... | 2,474 | 2,416 | 2,440 | 2,326 | 2,678 | ||||||||
| Cost Per Employee (Local Currency) | CZK per month | ... | 48,408 | 51,635 | 58,231 | 58,691 | 62,840 | ||||||||
| Material & Energy (As % of Sales) | % | ... | ... | ... | ... | ... | ... | ... | ... | 60.2 | 51.9 | 52.7 | 47.0 | ||
| Services (As % of Sales) | % | ... | ... | ... | ... | ... | ... | ... | ... | 17.6 | 16.4 | 16.3 | 15.1 | ||
| Staff Cost (As % of Sales) | % | ... | 5.34 | 4.52 | 4.59 | 5.06 | 5.15 | ||||||||
| Effective Tax Rate | % | ... | 15.0 | 19.2 | -8.85 | 4.08 | 5.41 | ||||||||
| Total Revenue Growth (5-year average) | % | ... | ... | ... | ... | ... | ... | 4.43 | 11.0 | 6.53 | 5.54 | 8.07 | |||
| Total Revenue Growth (10-year average) | % | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | 2.70 |
Get all company financials in excel:
By Helgi Library - December 4, 2020
Lenzing Biocel Paskov made a net profit of CZK 1,111 mil in 2019, down 21.6% compared to the previous year. Total sales reached CZK 5,285 mil, which is up 0.683% when compared to the previous year. Historically, between 2007 and 2019, the company’s...
By Helgi Library - December 4, 2020
Lenzing Biocel Paskov's total assets reached CZK 7,358 mil at the end of 2019, down 0.049% compared to the previous year. Current assets amounted to CZK 33,612 mil, or 457% of total assets while cash stood at CZK 1,585 mil at the end of 201...
By Helgi Library - December 4, 2020
Lenzing Biocel Paskov's total assets reached CZK 7,358 mil at the end of 2019, down 0.049% compared to the previous year. Current assets amounted to CZK 33,612 mil, or 457% of total assets while cash stood at CZK 1,585 mil at the end of 201...
By Helgi Library - December 4, 2020
Lenzing Biocel Paskov made a net profit of CZK 1,111 mil with revenues of CZK 5,285 mil in 2019, down by 21.6% and up by 0.683%, respectively, compared to the previous year. This translates into a net margin of 21.0%. Historically, between 2007 and 2019...
By Helgi Library - December 4, 2020
Lenzing Biocel Paskov made a net profit of CZK 1,111 mil with revenues of CZK 5,285 mil in 2019, down by 21.6% and up by 0.683%, respectively, compared to the previous year. This translates into a net margin of 21.0%. Historically, between 2007 and 2019...
By Helgi Library - December 4, 2020
Lenzing Biocel Paskov made a net profit of CZK 1,111 mil in 2019, down 21.6% compared to the previous year. Historically, between 2007 and 2019, the company's net profit reached a high of CZK 1,621 mil in 2017 and a low of CZK -99.0 mil in 2012. The resul...
By Helgi Library - December 4, 2020
Lenzing Biocel Paskov made a net profit of CZK 1,111 mil in 2019, down 21.6% compared to the previous year. Historically, between 2007 and 2019, the company's net profit reached a high of CZK 1,621 mil in 2017 and a low of CZK -99.0 mil in 2012. The resul...
By Helgi Library - December 4, 2020
Lenzing Biocel Paskov's net debt stood at CZK -1,587 mil and accounted for -25.2% of equity at the end of 2019. The ratio is down 6.88 pp compared to the previous year. Historically, the firm’s net debt to equity reached a high of 105% in 2013 and ...
By Helgi Library - December 4, 2020
Lenzing Biocel Paskov's net debt stood at CZK -1,587 mil and accounted for -25.2% of equity at the end of 2019. The ratio is down 6.88 pp compared to the previous year. Historically, the firm’s net debt to equity reached a high of 105% in 2013 and ...
By Helgi Library - December 4, 2020
Lenzing Biocel Paskov invested a total of CZK 260 mil in 2019, up 6.11% compared to the previous year. Historically, between 2008 - 2019, the company's investments stood at a high of CZK 958 mil in 2012 and a low of CZK -798 mil in 2015. ...
Biocel Paskov a.s. is a Czech Republic-based manufacturer of viscose pulp for the textile industry in Austria, the Netherlands, Estonia, and internationally. The Company was founded in 2001 and is based in Paskov, Czech Republic. Biocel Paskov a.s. operates as a subsidiary of Lenzing Aktiengesellschaft.
Lenzing Biocel Paskov has been growing its sales by 0.097% a year on average in the last 5 years. EBITDA has grown on average by 6.46% a year during that time to total of CZK 1,938 mil in 2019, or 36.7% of sales. That’s compared to 37.8% average margin seen in last five years.
The company netted CZK 1,111 mil in 2019 implying ROE of 17.7% and ROCE of 19.9%. Again, the average figures were 24.4% and 22.4%, respectively when looking at the previous 5 years.
Lenzing Biocel Paskov’s net debt amounted to CZK -1,587 mil at the end of 2019, or -25.2% of equity. When compared to EBITDA, net debt was -0.819x, down when compared to average of -0.380x seen in the last 5 years.
Helgi Library 
